Rickard John, Varma Niraj
Division of Cardiology, The Johns Hopkins Hospital, Baltimore, USA.
Curr Treat Options Cardiovasc Med. 2014 Apr;16(4):298. doi: 10.1007/s11936-014-0298-1.
Cardiac resynchronization therapy (CRT) is an important therapy in heart failure but 30 %‒40 % of patients may not respond. Improving this rate is an important goal and requires attention to candidate selection, intraoperative procedure, and postoperative follow-up. Factors to be considered are QRS morphology, duration, and left ventricular lead position with attention to paced effects on QRS. Postprocedure follow-up is critical to correct interfering conditions (eg, anodal capture, loss of 100 % biventricular pacing because of premature ventricular complexes (PVCs) or atrial fibrillation (AF). Echocardiographic improvement following CRT, which may take up to 18 months, is a potent predictor of long-term outcomes. Correcting the status of nonresponders, when possible, is important. Remote monitoring, in conjunction with CRT optimization clinics, may facilitate multidisciplinary follow-up and enable early intervention to improve outcome.
心脏再同步治疗(CRT)是心力衰竭的一种重要治疗方法,但30% - 40%的患者可能无反应。提高这一比例是一个重要目标,需要关注候选者选择、术中操作及术后随访。需要考虑的因素包括QRS波形态、时限以及左心室导线位置,并关注起搏对QRS波的影响。术后随访对于纠正干扰情况(如阳极夺获、由于室性早搏(PVC)或心房颤动(AF)导致100%双心室起搏丧失)至关重要。CRT治疗后超声心动图的改善可能需要长达18个月的时间,是长期预后的有力预测指标。尽可能纠正无反应者的状态很重要。远程监测结合CRT优化门诊,可能有助于多学科随访并实现早期干预以改善预后。